Community
Disney World is selling hotel rooms for $99 this winter — but there’s a catch
By Leila Ahmed
Ozempic, Wegovy and Zepbound get new FDA warning over rare condition
Leila Ahmed
Leila Ahmed
Reporter · Syracuse, NY
A graduate of the University at Buffalo, Leila has spent five years in journalism, previously working at a community-focused news outlet in Rochester, NY. She specializes in uncovering the diverse voices and cultural richness of Syracuse’s neighborhoods, bringing their stories to light.
More from Leila →Reporter · Tuesday, November 10, 2026 at 2:33 PM · 1 min read
People taking popular weight-loss and diabetes drugs are getting a new safety warning. The Food and Drug Administration is requiring all GLP-1 drugs to carry information about a potential increased risk of a rare eye condition that can cause permanent vision loss, according to the FDA’s Nov. 9 drug safety communication. The medications include Ozempic, Wegovy, Mounjaro and Zepbound.
Up nextDisney World is selling hotel rooms for $99 this winter — but there’s a catchCommunity · 1 min read
